Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics, |
RCV000408452 | SCV000281800 | likely pathogenic | Severe early-childhood-onset retinal dystrophy | 2016-01-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000763051 | SCV000893532 | pathogenic | Cone-rod dystrophy 3; Age related macular degeneration 2; Severe early-childhood-onset retinal dystrophy; Retinitis pigmentosa 19 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000085427 | SCV001219642 | pathogenic | not provided | 2024-07-31 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 60 of the ABCA4 protein (p.Ala60Val). This variant is present in population databases (rs55732384, gnomAD 0.007%). This missense change has been observed in individual(s) with Stargardt disease (PMID: 28118664, 28559085). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 99083). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ABCA4 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |
Blueprint Genetics | RCV001073359 | SCV001238900 | pathogenic | Retinal dystrophy | 2018-12-26 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000085427 | SCV004032963 | likely pathogenic | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | ABCA4: PM1, PM2, PM3, PM5 |
Institute of Human Genetics, |
RCV001073359 | SCV005070530 | likely pathogenic | Retinal dystrophy | 2023-01-01 | criteria provided, single submitter | clinical testing | |
Retina International | RCV000085427 | SCV000117564 | not provided | not provided | no assertion provided | not provided | ||
Genomic Medicine Center of Excellence, |
RCV000408452 | SCV004801149 | uncertain significance | Severe early-childhood-onset retinal dystrophy | 2024-03-14 | flagged submission | research | |
Ophthalmo- |
RCV004558304 | SCV005046925 | pathogenic | Stargardt disease 3 | no assertion criteria provided | research |